Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Genmab (CSE:GEN) and Medarex (MEDX) exchanged assets that had been co-owned by the companies, including a therapeutic MAb
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury